Last update:
Oncology news
Cancer risk awareness and concrete plans boosted gastric screening during COVID-19
A study conducted by researchers at University of Tsukuba revealed that individuals with higher cancer-related health literacy, perceived susceptibility to gastric cancer, and encouragement from family members or health care ...
26 minutes ago
0
0
New targeted radiopharmaceutical therapy induces remission in pancreatic cancer model
A newly developed targeted radiopharmaceutical treatment can effectively slow tumor growth in pancreatic ductal adenocarcinoma (PDAC), according to new research published in the May issue of The Journal of Nuclear Medicine. ...
12 hours ago
0
5
Why breast cancer becomes more deadly with age
Researchers at Georgetown's Lombardi Comprehensive Cancer Center have identified a mechanism that may help explain a key reason why older people experience worse outcomes from breast cancer. The study implicates RAGE (Receptor ...
21 hours ago
0
14
Study reveals promising new therapy for non-Hodgkin lymphoma
Not all cancers respond to the same treatments or have the same genetic origins. Epstein–Barr virus (EBV), a common and highly contagious virus, has been found to cause certain cancers, including non-Hodgkin lymphoma (NHL). ...
13 hours ago
0
3
Experimental drug shows promise for some patients with advanced prostate cancer
For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are limited—and time matters. As the disease progresses, the window for effective, less intensive treatments begins ...
13 hours ago
0
8
Novel CAR T cell therapy moves into clinical studies
The University of Texas MD Anderson Cancer Center and CTMC, a joint venture between UT MD Anderson and Resilience, today announced that the Food and Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational ...
13 hours ago
0
4
Worse survival seen with tumor-infiltrating clonal hematopoiesis in patients with solid tumors
Tumor-infiltrating clonal hematopoiesis (TI-CH) is associated with worse survival among patients with solid tumors, according to a study published online May 7 in JAMA Oncology.
15 hours ago
0
1
Experimental drug shrinks advanced kidney tumors, clears cancer in one patient
A new Phase I clinical trial provides proof of concept for a potential therapy for treatment-resistant cancers, particularly kidney cancer. In the new study, published in Cell Reports Medicine, researchers tested a novel ...
May 14, 2026
0
35
AI platform decodes how cells 'talk' in cancer, Alzheimer's and other complex diseases
Scientists at Houston Methodist have developed an artificial intelligence platform that can decode how cells communicate inside the human body, opening a window into conditions such as Alzheimer's disease, cancer, and potentially ...
May 14, 2026
0
8
Cancer-linked viruses are showing up in Texas wastewater, opening a new path for public health
A study published in Applied and Environmental Microbiology is the first comprehensive approach to detect all known cancer-causing or oncogenic viruses concurrently by analyzing viral genomes in wastewater. The work, a collaboration ...
May 14, 2026
0
5
Hidden genetic defect linked to Kaposi sarcoma for the first time
A new study has uncovered a genetic cause that may explain why some people develop Kaposi sarcoma despite having no apparent immune deficiency. The rare cancer, which forms in the cells lining blood vessels, is caused by ...
May 14, 2026
0
2
Screening modestly reduces prostate cancer deaths, review finds
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated review finds. This is a shift from the previous version of the review, which did not find sufficient ...
May 14, 2026
0
5
Novel tool enables high-precision, low-cost pediatric leukemia diagnostics
Researchers have introduced a novel diagnostics method that can more sensitively detect gene fusions in B-cell acute lymphoblastic leukemia (B-ALL), the most common type of pediatric cancer, compared to other publicly available ...
May 14, 2026
0
4
Diagnostic marker aids diagnosis for aggressive prostate cancer
The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly other aggressive prostate cancer subtypes that are difficult to diagnose due to a loss of traditional ...
May 14, 2026
0
3
Tumor gene changes linked to shorter gallbladder cancer survival, analysis shows
Gallbladder cancer (GBC) is an extremely aggressive biliary tract malignancy characterized by silent early progression, late-stage diagnosis and poor prognosis. It is one of the most lethal gastrointestinal cancers, with ...
May 14, 2026
0
2
Missing patient information in a national database may create blind spots in cancer data
A significant number of cancer patients—particularly those with more advanced cancers who are more likely to receive care at community hospitals, safety net hospitals, and rural medical centers—may have incomplete case information ...
May 14, 2026
0
2
Study shows that people who gain the most weight are at more than double the risk of certain cancers
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that people who gain the highest amount of weight across adulthood are at greatly increased risk of certain obesity-related ...
May 14, 2026
0
4
Cancer fatigue may ease within weeks as common stimulant shows benefit
A new meta-analysis in Journal of the National Comprehensive Cancer Network provides updated evidence that methylphenidate-type psychostimulants—a class of medication that increases dopamine and norepinephrine availability ...
May 14, 2026
0
4
Breast cancer cells with doubled genomes may dodge immunotherapy by turning off key immune signals
An epigenetic mechanism by which tumors manage to hide from the body's immune defenses has just been described by an international scientific team led by the University of Liège and the Dana-Farber Cancer Institute. These ...
May 13, 2026
0
16
New drug candidate that reprograms the immune system shows promise as a brain cancer treatment
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive and most common type of primary brain cancer in adults. In preclinical ...
May 13, 2026
0
8
A new approach to cancer vaccination yields more powerful T cells
MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.
May 13, 2026
0
10
Urine nanosensor tracks lung cancer signals and early fibrosis, moving toward clinical trials
A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing it could do more than first thought. Originally designed to detect early signs of ...
May 13, 2026
0
8
A 13-gene panel may help predict response to chemotherapy in triple-negative breast cancer
Researchers at The University of Texas MD Anderson Cancer Center have characterized cancer cell-specific features in the tumor microenvironment (TME) of early-stage triple-negative breast cancer (TNBC) tissues, identifying ...
May 13, 2026
0
11
Mouth stem cells could help beat brain cancer defenses
Stem cells found in the lining of the mouth could help make the most aggressive form of brain cancer easier to treat, according to new research from the University of Reading. The stem cells release a mixture of proteins ...
May 13, 2026
0
4
Future cancer therapy could use immunity to clean up damaged DNA by modulating AUF1
Researchers have identified a pathway that triggers an immune response in cells with defective DNA repair. In particular, the authors of a new paper demonstrated how the downregulation of AUF1 impairs DNA repair, followed ...
May 13, 2026
0
4
